Back to LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA

DXCMDXCM

Showing 8 of 30 quarters

Position history for LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MALORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's holdings in DEXCOM INC

No. Loring Wolcott & Coolidge Fiduciary Advisors exited its DXCM (Dexcom) position in Q2 2026. Its Q1 2026 13F listed 1,328 shares worth $85,019. Loring Wolcott & Coolidge Fiduciary Advisors already held DXCM in its Q1 2019 13F, the earliest on record, and held it in 28 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$152,919

Total Shares Change

-2,043

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$67.35
0
2026-Q1
Decreased
1,328
-33.2%
$85,0190.0%$62.80
0
2025-Q4
Unchanged
1,988
0.0%
$146,4560.0%$66.37
0
2025-Q3
Unchanged
1,988
0.0%
$141,2670.0%$67.29
0
2025-Q2
Unchanged
1,988
0.0%
$173,5330.0%$87.29
0
2025-Q1
Unchanged
1,988
0.0%
$132,9180.0%$68.29
0
2024-Q4
Decreased
1,988
-2.7%
$174,0100.0%$77.77
0
2024-Q3
Unchanged
2,043
0.0%
$152,9190.0%$67.04
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used